In this Explainer episode, Jeff Stier tells the innovative story of Impossible Burger, a company that developed leghemoglobin to mimic the taste of meat in non-meat-based products. Instead of rushing to regulate this new development, FDA took a hands-off approach, allowing the company to bring a beneficial, and widely recognized as safe, product to market. Jeff argues that innovation, rather than heavy-handed regulation, ought to be the primary way of reducing harm.
Featuring:
- Jeff Stier, Senior Fellow, Consumer Choice Center and Taxpayers Protection Alliance
Visit our website –
www.RegProject.org – to learn more, view all of our content, and connect with us on social media.
RTP's Fourth Branch Podcast